Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2004-05-03
2009-12-29
Blanchard, David J. (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S388100, C530S388220, C530S388800, C530S391700, C424S141100, C424S142100, C424S143100, C424S155100, C424S181100, C424S183100, C435S069600, C435S070210, C435S330000, C435S449000
Reexamination Certificate
active
07638605
ABSTRACT:
This invention relates to human antibodies that bind to human insulin-like growth factor-1 receptor (IGF-IR), to derivatives of these antibodies (Fabs, single chain antibodies, bi-specific antibodes, or fusion proteins), and to uses of the antibodies and derivatives in therapeutic, and diagnostic methods. The invention relates to nucleic acids encoding the anti-IGF-IR, methods of generating the antibodies and expression. The invention further relates to combination therapies using ant-IGF-IR antibodies with anti-neoplastic drugs.
REFERENCES:
patent: 4774321 (1988-09-01), Rosner et al.
patent: 5200509 (1993-04-01), Spencer et al.
patent: 5262308 (1993-11-01), Baserga
patent: 5597563 (1997-01-01), Beschorner
patent: 5624805 (1997-04-01), Spencer et al.
patent: 5670341 (1997-09-01), Spencer et al.
patent: 5681818 (1997-10-01), Spencer et al.
patent: 5688505 (1997-11-01), Webb et al.
patent: 5705157 (1998-01-01), Greene
patent: 5798266 (1998-08-01), Quay et al.
patent: 5852174 (1998-12-01), Vlassara et al.
patent: 5869337 (1999-02-01), Crabtree et al.
patent: 5872220 (1999-02-01), Kiefer et al.
patent: 5891722 (1999-04-01), Fuks et al.
patent: 5939269 (1999-08-01), Goldfine et al.
patent: 5942412 (1999-08-01), Prager et al.
patent: 5968508 (1999-10-01), Goldfine
patent: 5968758 (1999-10-01), Fuks et al.
patent: 5977307 (1999-11-01), Friden et al.
patent: 5993818 (1999-11-01), Torchilin et al.
patent: 6071891 (2000-06-01), Low et al.
patent: 6084085 (2000-07-01), Baserga et al.
patent: 6090383 (2000-07-01), Dasch et al.
patent: 6316462 (2001-11-01), Bishop et al.
patent: 6368826 (2002-04-01), Ligensa et al.
patent: 6875741 (2005-04-01), Pillutla et al.
patent: 7037498 (2006-05-01), Cohen et al.
patent: 7071160 (2006-07-01), Yamano et al.
patent: 7071300 (2006-07-01), Deshayes et al.
patent: 7217796 (2007-05-01), Wang et al.
patent: 7241444 (2007-07-01), Goetsch et al.
patent: 7300655 (2007-11-01), Hansen et al.
patent: 7329745 (2008-02-01), Fujita-Yamaguchi
patent: 7371378 (2008-05-01), Cohen et al.
patent: 7432244 (2008-10-01), Deshayes et al.
patent: 2003/0021780 (2003-01-01), Smith et al.
patent: 2003/0165502 (2003-09-01), Fujita-Yamaguchi
patent: 2003/0235582 (2003-12-01), Singh et al.
patent: 2004/0057950 (2004-03-01), Waksal et al.
patent: 2004/0102360 (2004-05-01), Barnett et al.
patent: 2004/0116330 (2004-06-01), Naito et al.
patent: 2004/0141958 (2004-07-01), Steinaa et al.
patent: 2004/0202651 (2004-10-01), Cohen et al.
patent: 2004/0202655 (2004-10-01), Morton et al.
patent: 2004/0228859 (2004-11-01), Graus et al.
patent: 2004/0265307 (2004-12-01), Singh et al.
patent: 2005/0008642 (2005-01-01), Graus et al.
patent: 2005/0079184 (2005-04-01), Hsing-Chang et al.
patent: 2005/0084906 (2005-04-01), Goetsch et al.
patent: 2005/0136063 (2005-06-01), Wang et al.
patent: 2005/0186203 (2005-08-01), Singh et al.
patent: 2005/0244408 (2005-11-01), Cohen et al.
patent: 2005/0249728 (2005-11-01), Singh et al.
patent: 2005/0249730 (2005-11-01), Goetsch et al.
patent: 2005/0281812 (2005-12-01), Cohen et al.
patent: 2006/0106203 (2006-05-01), Winter et al.
patent: 2006/0134172 (2006-06-01), Shepard et al.
patent: 2006/0149033 (2006-07-01), Deshayes et al.
patent: 2006/0193772 (2006-08-01), Ochiai et al.
patent: 2006/0233814 (2006-10-01), Goldmakher et al.
patent: 2007/0009970 (2007-01-01), Heller et al.
patent: 2007/0196376 (2007-08-01), Raeber et al.
patent: 0294021 (1988-12-01), None
patent: 0369943 (1990-05-01), None
patent: 0375438 (1990-06-01), None
patent: 8906692 (1989-07-01), None
patent: 9744352 (1997-11-01), None
patent: 02053596 (2002-07-01), None
patent: 03059951 (2003-07-01), None
patent: 2004071529 (2004-08-01), None
patent: 2004083248 (2004-09-01), None
patent: 2004087756 (2004-10-01), None
patent: 2005005635 (2005-01-01), None
patent: 2005052005 (2005-06-01), None
patent: 2005082415 (2005-09-01), None
patent: 2006008639 (2006-01-01), None
patent: 2006013472 (2006-02-01), None
patent: 2006060419 (2006-06-01), None
patent: 2006069202 (2006-06-01), None
patent: 2007000328 (2007-01-01), None
patent: 2007012614 (2007-02-01), None
patent: 2007031875 (2007-03-01), None
Blanchard David J.
ImClone LLC
Jivraj Sanjay M.
LandOfFree
Fully human antibodies directed against the human... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fully human antibodies directed against the human..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fully human antibodies directed against the human... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4092272